(Q82090238)

English

FDA approves brentuximab vedotin for Hodgkin lymphoma and systemic anaplastic large-cell lymphoma

scientific article published on 01 September 2011

Statements

FDA approves brentuximab vedotin for Hodgkin lymphoma and systemic anaplastic large-cell lymphoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit